Drug Profile
Research programme: angiogenesis inhibitors - IVAX Drug Research Institute
Latest Information Update: 05 Jul 2007
Price :
$50
*
At a glance
- Originator IVAX Drug Research Institute
- Class Small molecules
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 10 Sep 2001 The Institute for Drug Research is now called the IVAX Drug Research Institute
- 02 Oct 2000 Preclinical development for Cancer in Hungary (unspecified route)